Navigation Links
Hormone refractory prostate cancers more likely to spread to other organs
Date:2/20/2008

ally, doctors dont like to use hormone treatment which stops the production of testosterone - early on in the treatment of prostate cancer because of the harsh side effects, which can include hot flashes, osteoporosis and sexual dysfunction. In the past, doctors have waited until the cancer spread to prescribe hormone therapy, Reiter said.

This study may provide additional scientific rationale to support the recent trend that giving hormone treatment early on is better than waiting, Reiter said. Early hormone treatment in this group of men might allow them to live longer. High levels of androgen receptor in the primary tumor might also predict which cancers are more likely to spread despite initial surgery or radiation.

This strategy could be particularly effective in high risk men, those with large primary tumors, high Gleason scores and those that have lymph node involvement at diagnosis.

Prostate cancer is the most common cancer in men in the United States. This year alone, more than 218,000 men will be diagnosed with prostate cancer. About 27,000 men will die from the disease.

Reiter and his team will next seek to understand the mechanism by which androgen receptor overexpression is causing the cancer to spread. If they can uncover the mechanism, they might find new and better targets for drug therapy in addition to targeting the androgen receptor.


'/>"/>

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Newly discovered role of thyroid hormone during pregnancy
2. Stress hormone impacts memory, learning in diabetic rodents
3. Moving beyond tamoxifen: Drug discovery and the future of selective hormone receptor modulators
4. Diabetes, Growth Disorders Drive Sales of Pediatric Hormone Drugs
5. Sex Hormones Dont Seem to Affect Prostate Cancer Risk
6. Hormone Therapy Only Helps Some Older Men With Prostate Cancer
7. FDA Warns Against Bio-Identical Hormone Therapy
8. FDA Asserts New Policy to Restrict Womens Access to Bioidentical Hormones
9. Just 4 months of hormone therapy can delay prostate cancer growth by up to 8 years
10. Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients
11. Hormone may be new drug target for preventing lymphedema, tumor spread
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... ERT, a ... cloud analytics and workflow solutions today announced the complete faculty of its ... 2015. The esteemed faculty of worldwide pharmaceutical and industry experts will lead ...
(Date:9/3/2015)... ... ... an unavoidable result of incision or injury to the skin. Unsightly as it may be, ... of a scar is dependent on many factors – the size and depth of the ... near invisibility on their own over a period of months,” says Dr. Jocelyn Lieb ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... Mum n ... . The all-new product offers an extra-large size that gives maximum protection from sun ... with easy-to-use button attachment straps that deliver non-slip assurance by keeping the cover securely ...
(Date:9/3/2015)... Horeb, WI (PRWEB) , ... September 03, 2015 , ... ... us after becoming dissatisfied with the traditional health care model, where the primary care ... group of individuals who want to become educated about their health issues and empowered ...
(Date:9/3/2015)... ... September 03, 2015 , ... Local filmmakers and now co-hosts ... Michael Habernig from Path 11 Productions have had great success in launching their Path11 ... featured Hay House authors, Teal Swan who is the well known Spiritual Catalyst and ...
Breaking Medicine News(10 mins):Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 3Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4Health News:Mum n Me Announces New Baby Car Seat Cover 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 3
... Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned ... that RLL has received approval from the U.S. ... Quinapril Hydrochloride & Hydrochlorothiazide (Quinapril + HCTZ) ... for the drug was submitted by Ranbaxy, from ...
... published in the Spring 2009 edition of Multiple ... Spinal Association ( www.UnitedSpinal.org ) and the North American ... importance of understanding the biological onset of Multiple Sclerosis ... greater understanding and treatment of MS in adults. The ...
... Two new Directors join the Board of the ... (Infectious Disease Research Institute) announced today that Dr. ... President (SVP) Scientific Affairs to assist the organization ... programs. Dr. Auditore-Hargreaves has a proven track record ...
... Hurricane Ike during a free public forum at Rice University ... Ed Emmett will discuss the leadership challenges they had to ... Guiding Houston through the Storm" will be held from 6 ... Rice campus, 6100 Main St. , In conjunction with ...
... Sick or injured African-American patients wait about ... before being transferred to an inpatient hospital bed ... national study published in the journal Academic ... underscore the urgency to find equitable, cost-effective solutions ...
... children and adolescents, with the active involvement of their ... the Seven Steps to Success described in the current ... published by Mary Ann Liebert, Inc. The article is ... A team of experts that includes physicians and psychologists ...
Cached Medicine News:Health News:Ranbaxy Secures Final FDA Approval for Quinapril Hydrochloride + Hydrochlorothiazide Tablets 2Health News:United Spinal Association Report Reveals the Importance of Studying Multiple Sclerosis in Children: Developing New Insights into MS in Adults 2Health News:IDRI Announces Appointment of Dr. Karen Auditore-Hargreaves as SVP, Scientific Affairs 2Health News:IDRI Announces Appointment of Dr. Karen Auditore-Hargreaves as SVP, Scientific Affairs 3Health News:Public forum at Rice with mayor and county judge marks 6-month Ike anniversary 2Health News:Racial disparities in emergency department length of stay point to added risks for minority patients 2Health News:Racial disparities in emergency department length of stay point to added risks for minority patients 3Health News:7 steps to successful child and adolescent weight loss 2
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015 ... the addition of the "An Introduction to ... - November 2-3, 2015)" conference to their ... a comprehensive introduction to the regulations and requirements ... will be highly interactive, using real life examples ...
(Date:9/2/2015)... 2, 2015 Research and Markets ( http://www.researchandmarkets.com/research/6x789c/new_eu ... EU Pharmacovigilance Legislation (London, UK - November 16-17, 2015)" ... 15 new EU modules concerning Pharmacovigilance are a major ... in Europe . The intention of ... their requirements, examine how they overlap and fit together ...
(Date:9/2/2015)... Sept. 2, 2015  ArmaGen, Inc., a privately ... to treat severe neurological disorders, announced today that ... multi-center Phase 1/2a clinical trial of AGT-181 in ... AGT-181 is an investigational enzyme ... I. The most severe form of MPS I, ...
Breaking Medicine Technology:An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 3ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 4
... Inc. (NKI) ( www.neuro-kinetics.com ), manufacturers of noninvasive medical ... neurological conditions, said today that it has received a ... Affordable Care Act to further the company,s ongoing clinical ... sports concussions. The Therapeutic Discovery grant was ...
... ATLANTA, Nov. 18, 2010 UCB, Inc., ... medications to treat immunology disorders, today announced the winners ... for outstanding individuals affected by this condition. UCB is ... deserving students seek personal growth through higher education. ...
Cached Medicine Technology:Neuro Kinetics Receives HHS Therapeutic Discovery Grant to Further Research Into Early Diagnosis of Sports Concussions 2Neuro Kinetics Receives HHS Therapeutic Discovery Grant to Further Research Into Early Diagnosis of Sports Concussions 32010 UCB Rheumatoid Arthritis Family Scholarship Winners Announced 22010 UCB Rheumatoid Arthritis Family Scholarship Winners Announced 32010 UCB Rheumatoid Arthritis Family Scholarship Winners Announced 4
Transcranial vascular DWL doppler....
... 9100HS is a powerful automated system capable ... Choose from 6 user-programmable test protocols to ... exam. Any tests not included in the ... be handled using the Doppler, PVR and ...
The CD Horizon M8 Spinal System provide spine surgeons comprehensive solutions for the treatment of spinal deformities, trauma reconstruction, and degenerative conditions....
... The VasoGuard from VIASYS Neurocare ... forward in physiologic vascular diagnosis. Exceptional ... and system reliability. , ,VasoGuard delivers ... The unique QuickConnect arm for cuff ...
Medicine Products: